ArticleThe Lancet. Global health2019

Efficacy of the 1-year (13-cycle) segesterone acetate and ethinylestradiol contraceptive vaginal system: results of two multicentre, open-label, single-arm, phase 3 trials.

David F Archer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.